Genetic approaches to interfere with malaria transmission by vector mosquitoes

Trends in Biotechnology

Volumn 31, Issue 3, 2013, Pages 185-193

  Wang, Sibao ^a   Jacobs Lorena, Marcelo ^b  

^a INSTITUTE OF PLANT PHYSIOLOGY AND ECOLOGY   (China)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Effector molecules; Malaria; Mosquitoes; Paratransgenesis; Transgenesis

Indexed keywords

FIELD APPLICATION; GENETIC MANIPULATIONS; GENETIC MODIFICATIONS; MALARIA; MALARIA TRANSMISSION; MOSQUITOES; PARATRANSGENESIS; TRANSGENESIS;

GENETIC ENGINEERING; MOLECULES;

DISEASES;

CECROPIN; DEFENSIN; PLASMINOGEN;

AEDES AEGYPTI; ANOPHELES GAMBIAE; ANOPHELES STEPHENSI; BEAUVERIA BASSIANA; CULEX PIPIENS; DNA MODIFICATION; GAMETOCYTE; GENETIC ENGINEERING; GENETIC MANIPULATION; HUMAN; IMMUNE SYSTEM; MALARIA; MALARIA CONTROL; METARHIZIUM; MIDGUT; MOSQUITO; NONHUMAN; PLASMODIUM; PLASMODIUM (LIFE CYCLE STAGE); PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; SPOROZOITE; SYMBIONT; TRANSGENICS;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CULICIDAE; DISEASE TRANSMISSION, INFECTIOUS; DISEASE VECTORS; MALARIA; MICROBIAL INTERACTIONS; MOSQUITO CONTROL; PLASMODIUM;

EID: 84875269445     PISSN: 01677799     EISSN: 18793096     Source Type: Journal    
DOI: 10.1016/j.tibtech.2013.01.001     Document Type: Review

References (100)

1. Murray C.J., et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
2. Ghosh A., et al. The journey of the malaria parasite in the mosquito: hopes for the new century. Parasitol. Today 2000, 16:196-201.
3. Greenwood B.M., et al. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 2008, 118:1266-1276.
4. Trape J.F., et al. Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect. Dis. 2011, 11:925-932.
5. A research agenda for malaria eradication: basic science and enabling technologies. PLoS Med. 2011, 8:e1000399. The malERA Consultative Group on Basic Science Enabling Technologies.
6. Taylor L.H. Infection rates in, and the number of Plasmodium falciparum genotypes carried by Anopheles mosquitoes in Tanzania. Ann. Trop. Med. Parasitol. 1999, 93:659-662.
7. Whitten M.M.A., et al. Mosquito midguts and malaria: cell biology, compartmentalization and immunology. Parasite Immunol. 2006, 28:121-130.
8. Abraham E.G., Jacobs-Lorena M. Mosquito midgut barriers to malaria parasite development. Insect Biochem. Mol. Biol. 2004, 34:667-671.
9. Drexler A.L., et al. Plasmodium development in the mosquito: biology bottlenecks and opportunities for mathematical modeling. Trends Parasitol. 2008, 24:333-336.
10. Ghosh A.K., et al. Targeting Plasmodium ligands on mosquito salivary glands and midgut with a phage display peptide library. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:13278-13281.
11. Ito J., et al. Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite. Nature 2002, 417:452-455.
12. Moreira L.A., et al. Bee venom phospholipase inhibits malaria parasite development in transgenic mosquitoes. J. Biol. Chem. 2002, 277:40839-40843.
13. Yoshida S., et al. Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs malaria parasite development. PLoS Pathog. 2007, 3:e192.
14. Dong Y., et al. Engineered anopheles immunity to Plasmodium infection. PLoS Pathog. 2011, 7:e1002458.
15. Corby-Harris V., et al. Activation of Akt signaling reduces the prevalence and intensity of malaria parasite infection and lifespan in Anopheles stephensi mosquitoes. PLoS Pathog. 2010, 6:e1001003.
16. Isaacs A.T., et al. Engineered resistance to Plasmodium falciparum development in transgenic Anopheles stephensi. PLoS Pathog. 2011, 7:e1002017.
17. Abraham E.G., et al. Driving midgut-specific expression and secretion of a foreign protein in transgenic mosquitoes with AgAper1 regulatory elements. Insect Mol. Biol. 2005, 14:271-279.
18. Chen C.H., et al. A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila. Science 2007, 316:597-600.
19. Windbichler N., et al. A synthetic homing endonuclease-based gene drive system in the human malaria mosquito. Nature 2011, 473:212-215.
20. Deredec A., et al. Requirements for effective malaria control with homing endonuclease genes. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E874-E880.
21. National Center for Infectious Disease Mosquitoes. Division of Parasitic Disease 2004, p. 6.
22. Coutinho-Abreu I.V., et al. Transgenesis and paratransgenesis to control insect-borne diseases: current status and future challenges. Parasitol. Int. 2010, 59:1-8.
23. Powell J.R., et al. Population structure, speciation, and introgression in the Anopheles gambiae complex. Parassitologia 1999, 41:101-113.
24. Catteruccia F., et al. Impact of genetic manipulation on the fitness of Anopheles stephensi mosquitoes. Science 2003, 299:1225-1227.
25. Li C., et al. Fitness of transgenic Anopheles stephensi mosquitoes expressing the SM1 peptide under the control of a vitellogenin promoter. J. Hered. 2008, 99:275-282.
26. Kokoza V., et al. Blocking of Plasmodium transmission by cooperative action of Cecropin A and Defensin A in transgenic Aedes aegypti mosquitoes. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:8111-8116.
27. Vizioli J., et al. Gambicin: a novel immune responsive antimicrobial peptide from the malaria vector Anopheles gambiae. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:12630-12635.
28. Kim W., et al. Ectopic expression of a cecropin transgene in the human malaria vector mosquito Anopheles gambiae (Diptera: Culicidae): effects on susceptibility to Plasmodium. J. Med. Entomol. 2004, 41:447-455.
29. Conde R., et al. Scorpine, an anti-malaria and anti-bacterial agent purified from scorpion venom. FEBS Lett. 2000, 471:165-168.
30. Wang S., et al. Fighting malaria with engineered symbiotic bacteria from vector mosquitoes. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:12734-12739.
31. Maciel C., et al. Anti-plasmodium activity of angiotensin II and related synthetic peptides. PLoS ONE 2008, 3:e3296.
32. Gwadz R.W., et al. Effects of magainins and cecropins on the sporogonic development of malaria parasites in mosquitoes. Infect. Immun. 1989, 57:2628-2633.
33. Possani L.D., et al. From noxiustoxin to Shiva-3, a peptide toxic to the sporogonic development of Plasmodium berghei. Toxicon 1998, 36:1683-1692.
34. Moreira C.K., et al. Effect of the antimicrobial peptide gomesin against different life stages of Plasmodium spp. Exp. Parasitol. 2007, 116:346-353.
35. Ghosh A.K., et al. Plasmodium ookinetes coopt mammalian plasminogen to invade the mosquito midgut. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:17153-17158.
36. de Lara Capurro M., et al. Virus-expressed, recombinant single-chain antibody blocks sporozoite infection of salivary glands in Plasmodium gallinaceum-infected Aedes aegypti. Am. J. Trop. Med. Hyg. 2000, 62:427-433.
37. Yoshida S., et al. Bacteria expressing single-chain immunotoxin inhibit malaria parasite development in mosquitoes. Mol. Biochem. Parasitol. 2001, 113:89-96.
38. Zieler H., et al. A snake venom phospholipase A(2) blocks malaria parasite development in the mosquito midgut by inhibiting ookinete association with the midgut surface. J. Exp. Biol. 2001, 204:4157-4167.
39. Bhatnagar R.K., et al. Synthetic propeptide inhibits mosquito midgut chitinase and blocks sporogonic development of malaria parasite. Biochem. Biophys. Res. Commun. 2003, 304:783-787.
40. Shao L., et al. The peritrophic matrix of hematophagous insects. Arch. Insect Biochem. Physiol. 2001, 47:119-125.
41. Christophides G.K., et al. Comparative and functional genomics of the innate immune system in the malaria vector Anopheles gambiae. Immunol. Rev. 2004, 198:127-148.
42. Brown A.E., et al. Stable and heritable gene silencing in the malaria vector Anopheles stephensi. Nucleic Acids Res. 2003, 31:e85.
43. Wang S., et al. Local adaptation of an introduced transgenic insect fungal pathogen due to new beneficial mutations. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:20449-20454.
44. Farenhorst M., et al. Fungal infection counters insecticide resistance in African malaria mosquitoes. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17443-17447.
45. Mnyone L.L., et al. First report of Metarhizium anisopliae IP 46 pathogenicity in adult Anopheles gambiae s.s. and An. arabiensis (Diptera; Culicidae). Parasit. Vectors 2009, 2:59.
46. Scholte E.J., et al. An entomopathogenic fungus for control of adult African malaria mosquitoes. Science 2005, 308:1641-1642.
47. Blanford S., et al. Fungal pathogen reduces potential for malaria transmission. Science 2005, 308:1638-1641.
48. Hancock P.A., et al. An age-structured model to evaluate the potential of novel malaria-control interventions: a case study of fungal biopesticide sprays. Proc. Biol. Sci. 2009, 276:71-80.
49. Thomas M.B., Read A.F. Can fungal biopesticides control malaria?. Nat. Rev. Microbiol. 2007, 5:377-383.
50. Fang W.G., et al. Development of transgenic fungi that kill human malaria parasites in mosquitoes. Science 2011, 331:1074-1077.
51. Ward T.W., et al. Aedes aegypti transducing densovirus pathogenesis and expression in Aedes aegypti and Anopheles gambiae larvae. Insect Mol. Biol. 2001, 10:397-405.
52. Ren X., et al. Viral paratransgenesis in the malaria vector Anopheles gambiae. PLoS Pathog. 2008, 4:e1000135.
53. Ma M., et al. Discovery of DNA viruses in wild-caught mosquitoes using small RNA high throughput sequencing. PLoS ONE 2011, 6:e24758.
54. Carlson J., et al. Densoviruses for control and genetic manipulation of mosquitoes. Adv. Virus Res. 2006, 68:361-392.
55. Weiss B., Aksoy S. Microbiome influences on insect host vector competence. Trends Parasitol. 2011, 27:514-522.
56. Durvasula R.V., et al. Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:3274-3278.
57. Chang T.L., et al. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:11672-11677.
58. Favia G., et al. Bacteria of the genus Asaia stably associate with Anopheles stephensi, an Asian malarial mosquito vector. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:9047-9051.
59. Rao S., et al. Toward a live microbial microbicide for HIV: commensal bacteria secreting an HIV fusion inhibitor peptide. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11993-11998.
60. Riehle M.A., et al. Using bacteria to express and display anti-Plasmodium molecules in the mosquito midgut. Int. J. Parasitol. 2007, 37:595-603.
61. Straif S.C., et al. Midgut bacteria in Anopheles gambiae and An. funestus (Diptera: Culicidae) from Kenya and Mali. J. Med. Entomol. 1998, 35:222-226.
62. Wang Y., et al. Dynamic gut microbiome across life history of the malaria mosquito Anopheles gambiae in Kenya. PLoS ONE 2011, 6:e24767.
63. Pumpuni C.B., et al. Bacterial population dynamics in three anopheline species: the impact on Plasmodium sporogonic development. Am. J. Trop. Med. Hyg. 1996, 54:214-218.
64. Andrews J.H., Harris R.F. The ecology and biogeography of microorganisms on plant surfaces. Annu. Rev. Phytopathol. 2000, 38:145-180.
65. Pusey P.L. Biological control agents for fire blight of apple compared under conditions limiting natural dispersal. Plant Dis. 2002, 86:639-644.
66. Pusey P.L. Crab apple blossoms as a model for research on biological control of fire blight. Phytopathology 1997, 87:1096-1102.
67. Dong Y., et al. Implication of the mosquito midgut microbiota in the defense against malaria parasites. PLoS Pathog. 2009, 5:e1000423.
68. Meister S., et al. Immune signaling pathways regulating bacterial and malaria parasite infection of the mosquito Anopheles gambiae. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11420-11425.
69. Cirimotich C.M., et al. Natural microbe-mediated refractoriness to Plasmodium infection in Anopheles gambiae. Science 2011, 332:855-858.
70. Boissiere A., et al. Midgut microbiota of the malaria mosquito vector Anopheles gambiae and interactions with Plasmodium falciparum infection. PLoS Pathog. 2012, 8:e1002742.
71. Damiani C., et al. Paternal transmission of symbiotic bacteria in malaria vectors. Curr. Biol. 2008, 18:R1087-R1088.
72. Favia G., et al. Bacteria of the genus Asaia: a potential paratransgenic weapon against malaria. Adv. Exp. Med. Biol. 2008, 627:49-59.
73. Werren J.H., et al. Wolbachia: master manipulators of invertebrate biology. Nat. Rev. Microbiol. 2008, 6:741-751.
74. Iturbe-Ormaetxe I., et al. Wolbachia and the biological control of mosquito-borne disease. EMBO Rep. 2011, 12:508-518.
75. Moreira L.A., et al. A Wolbachia symbiont in Aedes aegypti limits infection with dengue, Chikungunya, and Plasmodium. Cell 2009, 139:1268-1278.
76. Kambris Z., et al. Immune activation by life-shortening Wolbachia and reduced filarial competence in mosquitoes. Science 2009, 326:134-136.
77. Bian G., et al. The endosymbiotic bacterium Wolbachia induces resistance to dengue virus in Aedes aegypti. PLoS Pathog. 2010, 6:e1000833.
78. Hughes G.L., et al. Wolbachia infections are virulent and inhibit the human malaria parasite Plasmodium falciparum in Anopheles gambiae. PLoS Pathog. 2011, 7:e1002043.
79. Walker T., Moreira L.A. Can Wolbachia be used to control malaria?. Mem. Inst. Oswaldo Cruz 2011, 106:212-217.
80. Ignatova E.A., et al. The yeast flora of blood-sucking mosquitoes. Mikrobiol. Z. 1996, 58:12-15.
81. Ricci I., et al. The yeast Wickerhamomyces anomalus (Pichia anomala) inhabits the midgut and reproductive system of the Asian malaria vector Anopheles stephensi. Environ. Microbiol. 2011, 13:911-921.
82. Ricci I., et al. Different mosquito species host Wickerhamomyces anomalus (Pichia anomala): perspectives on vector-borne diseases symbiotic control. Antonie Van Leeuwenhoek 2011, 99:43-50.
83. Hurwitz I., et al. Paratransgenic control of vector borne diseases. Int. J. Biol. Sci. 2011, 7:1334-1344.
84. Riehle M.A., Jacobs-Lorena M. Using bacteria to express and display anti-parasite molecules in mosquitoes: current and future strategies. Insect Biochem. Mol. Biol. 2005, 35:699-707.
85. Yoshida S., et al. A single-chain antibody fragment specific for the Plasmodium berghei ookinete protein Pbs21 confers transmission blockade in the mosquito midgut. Mol. Biochem. Parasitol. 1999, 104:195-204.
86. Tzschaschel B.D., et al. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of Shiga-like toxin IIeB subunit by Salmonella typhimurium aroA. Nat. Biotechnol. 1996, 14:765-769.
87. Bisi D.C., Lampe D.J. Secretion of anti-Plasmodium effector proteins from a natural Pantoea agglomerans isolate by using PelB and HlyA secretion signals. Appl. Environ. Microbiol. 2011, 77:4669-4675.
88. Benedict M.Q., Robinson A.S. The first releases of transgenic mosquitoes: an argument for the sterile insect technique. Trends Parasitol. 2003, 19:349-355.
89. Nolan T., et al. Developing transgenic Anopheles mosquitoes for the sterile insect technique. Genetica 2011, 139:33-39.
90. Alphey L., et al. Insect population suppression using engineered insects. Adv. Exp. Med. Biol. 2008, 627:93-103.
91. Carter V., Hurd H. Choosing anti-Plasmodium molecules for genetically modifying mosquitoes: focus on peptides. Trends Parasitol. 2010, 26:582-590.
92. Ghosh A., et al. Molecular strategies to study Plasmodium-mosquito interactions. Trends Parasitol. 2003, 19:94-101.
93. Jaynes J.M., et al. In vitro cytocidal effect of novel lytic peptides on Plasmodium falciparum and Trypanosoma cruzi. FASEB J. 1988, 2:2878-2883.
94. Arrighi R.B., et al. Cell-penetrating peptide TP10 shows broad-spectrum activity against both Plasmodium falciparum and Trypanosoma brucei brucei. Antimicrob. Agents Chemother. 2008, 52:3414-3417.
95. Gao B., et al. AdDLP, a bacterial defensin-like peptide, exhibits anti-Plasmodium activity. Biochem. Biophys. Res. Commun. 2009, 387:393-398.
96. Gao B., et al. Characterization of two linear cationic antimalarial peptides in the scorpion Mesobuthus eupeus. Biochimie 2010, 92:350-359.
97. Tian C., et al. Gene expression, antiparasitic activity, and functional evolution of the drosomycin family. Mol. Immunol. 2008, 45:3909-3916.
98. Li F., et al. An anti-chitinase malaria transmission-blocking single-chain antibody as an effector molecule for creating a Plasmodium falciparum-refractory mosquito. J. Infect. Dis. 2005, 192:878-887.
99. Franz A.W., et al. Stability and loss of a virus resistance phenotype over time in transgenic mosquitoes harbouring an antiviral effector gene. Insect Mol. Biol. 2009, 18:661-672.
100. Muller G.C., et al. Successful field trial of attractive toxic sugar bait (ATSB) plant-spraying methods against malaria vectors in the Anopheles gambiae complex in Mali, West Africa. Malar. J. 2010, 9:210.